Judith Hartmann, taking over as Bayer’s CFO next June, is a skilled mountaineer. Earlier this year, she climbed Aconcagua, a 22,838-foot peak in Argentina; it taught her “perseverance, adaptability ...

Bayer Aktiengesellschaft remains deeply undervalued despite ongoing operational and litigation headwinds, supporting a bullish stance. Q3/25 results were weak, but technicals and intrinsic value ...

Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer.

Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug which had previously showed to be ineffective in another trial. The ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will incubate local biotechs starting with Puhe BioPharma and Youngen Technology.

The Missouri Supreme Court has brought an end to a yearslong legal suit filed against Bayer over cancer claims surrounding its popular home and commercial herbicide, Roundup, Farmers' Advance reported ...

Bayer BAYN-1.66%decrease; red down pointing triangle reported a net loss for the third quarter due to litigation charges, though adjusted earnings rose, and said it aims to significantly contain risks ...

A federal judge in San Francisco gave final approval to a $38 million class action settlement in a case against Bayer over investors’ claims that it didn’t conduct due diligence before making a ...